This K23 study is an effectiveness-implementation hybrid type I design to determine the effectiveness of Motivational Interviewing at Intake (MII), relative to intake-as-usual on client engagement and mechanisms of engagement among adults seeking outpatient addiction treatment. We also will obtain personnel feedback on the feasibility of implementing MII into standard practice by having personnel from the addiction treatment study sites complete implementation climate measures before Motivational Interviewing (MI) training and post-clinical trial, as well as an individual interview on implementation feasibility post-trial.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of participants who attended the first outpatient treatment program session based on electronic medical record review
Timeframe: up to 36 weeks
Number of treatment sessions attended during the three-month outpatient treatment program based on electronic medical record review
Timeframe: up to 36 weeks
Number of participants who completed the three-month outpatient treatment program based on electronic medical record review
Timeframe: up to 36 weeks